1. Home
  2. ONCY vs HSPO Comparison

ONCY vs HSPO Comparison

Compare ONCY & HSPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • HSPO
  • Stock Information
  • Founded
  • ONCY 1998
  • HSPO 2014
  • Country
  • ONCY Canada
  • HSPO United States
  • Employees
  • ONCY N/A
  • HSPO N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • HSPO Blank Checks
  • Sector
  • ONCY Health Care
  • HSPO Finance
  • Exchange
  • ONCY Nasdaq
  • HSPO Nasdaq
  • Market Cap
  • ONCY 49.1M
  • HSPO 49.4M
  • IPO Year
  • ONCY 1999
  • HSPO 2022
  • Fundamental
  • Price
  • ONCY $0.34
  • HSPO $12.11
  • Analyst Decision
  • ONCY Strong Buy
  • HSPO
  • Analyst Count
  • ONCY 4
  • HSPO 0
  • Target Price
  • ONCY $4.33
  • HSPO N/A
  • AVG Volume (30 Days)
  • ONCY 820.6K
  • HSPO 3.5K
  • Earning Date
  • ONCY 05-14-2025
  • HSPO 01-01-0001
  • Dividend Yield
  • ONCY N/A
  • HSPO N/A
  • EPS Growth
  • ONCY N/A
  • HSPO N/A
  • EPS
  • ONCY N/A
  • HSPO N/A
  • Revenue
  • ONCY N/A
  • HSPO N/A
  • Revenue This Year
  • ONCY N/A
  • HSPO N/A
  • Revenue Next Year
  • ONCY N/A
  • HSPO N/A
  • P/E Ratio
  • ONCY N/A
  • HSPO $34.81
  • Revenue Growth
  • ONCY N/A
  • HSPO N/A
  • 52 Week Low
  • ONCY $0.34
  • HSPO $10.97
  • 52 Week High
  • ONCY $1.53
  • HSPO $12.41
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 24.92
  • HSPO 66.53
  • Support Level
  • ONCY $0.34
  • HSPO $11.82
  • Resistance Level
  • ONCY $0.45
  • HSPO $12.14
  • Average True Range (ATR)
  • ONCY 0.04
  • HSPO 0.02
  • MACD
  • ONCY -0.01
  • HSPO 0.03
  • Stochastic Oscillator
  • ONCY 2.50
  • HSPO 91.43

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About HSPO Horizon Space Acquisition I Corp.

Horizon Space Acquisition I Corp is a blank check company.

Share on Social Networks: